Literature DB >> 5763844

The visual field defect and ocular pressure level in open angle glaucoma.

M F Armaly.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5763844

Source DB:  PubMed          Journal:  Invest Ophthalmol        ISSN: 0020-9988


× No keyword cloud information.
  13 in total

1.  The screening of the central visual field.

Authors:  G K Krieglstein; K Andrae
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1975

2.  [Medicinal glaucoma therapy. What can we learn from large randomized clinical trials?].

Authors:  A G M Jünemann; C Huchzermeyer; R Rejdak
Journal:  Ophthalmologe       Date:  2013-12       Impact factor: 1.059

3.  Fluorescein angiography: its contributions towards understanding the mechanisms of visual loss in glaucoma.

Authors:  G L Spaeth
Journal:  Trans Am Ophthalmol Soc       Date:  1975

4.  Screening tonometry by technicians.

Authors:  G K Krieglstein
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1975

5.  Visual field defects in early open angle glaucoma.

Authors:  M F Armaly
Journal:  Trans Am Ophthalmol Soc       Date:  1971

6.  Effect of intravenous acetazolamide on relative arcuate scotomas and visual field in glaucoma simplex.

Authors:  G Paterson
Journal:  Proc R Soc Med       Date:  1970-09

7.  Ischaemic optic neuropathy in chronic simple glaucoma.

Authors:  I S Begg; S M Drance; V P Sweeney
Journal:  Br J Ophthalmol       Date:  1971-02       Impact factor: 4.638

Review 8.  [Diagnosis and therapy of pseudoexfoliation glaucoma].

Authors:  A G M Jünemann
Journal:  Ophthalmologe       Date:  2012-10       Impact factor: 1.059

9.  Variability of glaucomatous visual field defects in computerized perimetry.

Authors:  C Holmin; C E Krakau
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1979-06-15

10.  Clinical detection of abnormalities in central vision in chronic simple glaucoma using contrast sensitivity.

Authors:  J E Ross
Journal:  Int Ophthalmol       Date:  1985-09       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.